Author details

Full Name

Paul A Rudnick

Affiliation

ORCID

Career Start Year

1998

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
30617155	Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V.	Mol Cell Proteomics	2019
26860878	A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.	J Proteome Res	2016
25762020	MRM as a discovery tool?	Proteomics	2015
25693799	Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.	Mol Cell Proteomics	2015
24563535	Improved normalization of systematic biases affecting ion current measurements in label-free proteomics data.	Molecular and Cellular Proteomics	2014
24889059	Tandem mass spectral libraries of peptides in digests of individual proteins: Human Serum Albumin (HSA).	Molecular and Cellular Proteomics	2014
23319436	Interlaboratory studies and initiatives developing standards for proteomics.	Proteomics	2013
22941178	Developing qualitative LC-MS methods for characterization of Vaccinium berry Standard Reference Materials.	Analytical and Bioanalytical Chemistry	2013
24123856	Refining spectral library searching.	Proteomics	2013
24116745	Comprehensive analysis of protein digestion using six trypsins reveals the origin of trypsin as a significant source of variability in proteomics.	J Proteome Res	2013
24147600	Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources.	Analytical Chemistry	2013
23689285	Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).	Mol Cell Proteomics	2013
22522798	A proteomics performance standard to support measurement quality in proteomics.	Proteomics	2012
19858499	Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.	Mol Cell Proteomics	2010
20677825	Depletion of abundant plasma proteins and limitations of plasma proteomics.	Journal of Proteome Research	2010
19837981	Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses.	Mol Cell Proteomics	2010
20121140	Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma.	Anal Chem	2010
19921851	Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.	J Proteome Res	2010
19561596	Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.	Nat Biotechnol	2009
17256009	Proteomic analysis of steroid-triggered autophagic programmed cell death during Drosophila development.	Cell Death and Differentiation	2007
17409379	Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens.	J Histochem Cytochem	2007
17263328	Membrane proteome analysis of microdissected ovarian tumor tissues using capillary isoelectric focusing/reversed-phase liquid chromatography-tandem MS.	Anal Chem	2007
16739998	Characterization of the human salivary proteome by capillary isoelectric focusing/nanoreversed-phase liquid chromatography coupled with ESI-tandem MS.	Journal of Proteome Research	2006
16223239	Proteome analysis of microdissected tumor tissue using a capillary isoelectric focusing-based multidimensional separation platform coupled with ESI-tandem MS.	Anal Chem	2005
15707355	Integrated capillary isoelectric focusing/nano-reversed phase liquid chromatography coupled with ESI-MS for characterization of intact yeast proteins.	Journal of Proteome Research	2005
16083287	Large scale analysis of MASCOT results using a Mass Accuracy-based THreshold (MATH) effectively improves data interpretation.	Journal of Proteome Research	2005
15909503	Effects of chromatography conditions on intact protein separations for top-down proteomics.	Journal of Chromatography A	2005
11790752	Role of GlnK in NifL-mediated regulation of NifA activity in Azotobacter vinelandii.	Journal of Bacteriology	2002
11320130	Lethality of glnD null mutations in Azotobacter vinelandii is suppressible by prevention of glutamine synthetase adenylylation.	Microbiology (United Kingdom)	2001
11274131	glnD and mviN are genes of an essential operon in Sinorhizobium meliloti.	Journal of Bacteriology	2001
9620984	Characterization of the glnK-amtB operon of Azotobacter vinelandii.	Journal of Bacteriology	1998